The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
| ||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| 10x Genomics, Inc. | CL A COM | 88025u109 | 13,102,148 | 359,554 | SH | SOLE | 13,102,148 | 0 | 0 | ||
| Aadi Bioscience, Inc. | COM | 00032Q104 | 6,752,801 | 526,329 | SH | SOLE | 6,752,801 | 0 | 0 | ||
| Adicet Bio, Inc. | COM | 007002108 | 5,185,200 | 580,000 | SH | SOLE | 5,185,200 | 0 | 0 | ||
| Albireo Pharma, Inc. | COM | 01345P106 | 13,470,421 | 623,342 | SH | SOLE | 13,470,421 | 0 | 0 | ||
| Alpine Immune Sciences, Inc. | COM | 010392595 | 49,305,917 | 6,708,288 | SH | SOLE | 49,305,917 | 0 | 0 | ||
| Apexigen, Inc. | COM | 03759B102 | 1,292,084 | 1,894,551 | SH | SOLE | 1,292,084 | 0 | 0 | ||
| Arcus BioSciences, Inc. | COM | 03969f109 | 17,987,257 | 869,790 | SH | SOLE | 17,987,257 | 0 | 0 | ||
| Argenx SE | SHS | 04016x101 | 2,094,551 | 5,529 | SH | SOLE | 2,094,551 | 0 | 0 | ||
| AtriCure Inc. | COM | 004963C20 | 2,052,974 | 46,259 | SH | SOLE | 2,052,974 | 0 | 0 | ||
| Aura Biosciences, Inc. | COM | 05153U107 | 3,079,997 | 293,333 | SH | SOLE | 3,079,997 | 0 | 0 | ||
| BeyondSpring Inc. | SHS | 00BD36JB9 | 9,321,309 | 4,958,143 | SH | SOLE | 9,321,309 | 0 | 0 | ||
| Cue Health Inc. | COM | 229790100 | 18,590,482 | 8,980,909 | SH | SOLE | 18,590,482 | 0 | 0 | ||
| Equillium Inc. | COM | 29446K106 | 4,892,039 | 4,447,308 | SH | SOLE | 4,892,039 | 0 | 0 | ||
| Horizon Therapeutics PLC | COM | G46188101 | 8,978,820 | 78,900 | SH | SOLE | 8,978,820 | 0 | 0 | ||
| Illumnia, Inc. | COM | 452327109 | 16,349,690 | 80,859 | SH | SOLE | 16,349,690 | 0 | 0 | ||
| Mersana Therapeutics, Inc. | COM | 59045L106 | 5,299,010 | 904,268 | SH | SOLE | 5,299,010 | 0 | 0 | ||
| Nautilus Biotechnology, Inc. | COM | 63909J108 | 540,000 | 300,000 | SH | SOLE | 540,000 | 0 | 0 | ||
| NeuBase Therapeutics, Inc. | COM | 64132K102 | 190,200 | 1,000,000 | SH | SOLE | 190,200 | 0 | 0 | ||
| Owlet, Inc. | COM CL A | 69120X107 | 502,295 | 898,400 | SH | SOLE | 502,295 | 0 | 0 | ||
| Pacific Biosciences of California, Inc. | COM | 69404D108 | 11,974,473 | 1,463,872 | SH | SOLE | 11,974,473 | 0 | 0 | ||
| Prometheus Biosciences, Inc. | COM | 74349U108 | 27,500,000 | 250,000 | SH | SOLE | 27,500,000 | 0 | 0 | ||
| Scynexis Inc. | COM NEW | 811292200 | 866,666 | 555,555 | SH | SOLE | 866,666 | 0 | 0 | ||
| Seagen Inc. | COM | 812578102 | 2,957,529 | 23,014 | SH | SOLE | 2,957,529 | 0 | 0 | ||
| GeneDx Holdings Corp. | COM CL A | 81663L101 | 902,597 | 3,418,929 | SH | SOLE | 902,597 | 0 | 0 | ||
| Terns Pharmaceuticals, Inc. | COM | 880881107 | 7,271,421 | 714,285 | SH | SOLE | 7,271,421 | 0 | 0 | ||
| Zentalis Pharmaceuticals Inc. | COM | 98943L107 | 36,747,102 | 1,824,583 | SH | SOLE | 36,747,102 | 0 | 0 | ||